Globus Medical, Inc. announced the resignation of president, Dave Demski, after nearly 20 years with the company, with the last four and a half years as its CEO. The board of directors has named Daniel T. Scavilla as the company's President, effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.31 USD | +0.17% | +1.59% | +24.43% |
05-29 | BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating | MT |
05-20 | Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.43% | 8.94B | |
-6.21% | 180B | |
-0.08% | 109B | |
-3.09% | 68.93B | |
-4.84% | 46.41B | |
+12.85% | 45.43B | |
+8.23% | 43.26B | |
+19.71% | 30.05B | |
+17.65% | 25.19B | |
-7.44% | 23.34B |
- Stock Market
- Equities
- GMED Stock
- News Globus Medical, Inc.
- Globus Medical, Inc. Announces Executive Changes